Featured Stock for Investors: Johnson & Johnson (JNJ)


Featured Stock for Investors: Johnson & Johnson (JNJ)

Now we look at the Moving Averages, the 200-day is 5.16%, the 50-day is -0.83% and the 20-day is -0.58%. The Klingenstein Fields & Co Llc holds 933,046 shares with $123.43M value, down from 936,802 last quarter. Johnson & Johnson now has $354.74B valuation. The stock declined 0.17% or $0.22 reaching $133 per share. About 495,429 shares traded.

Shares of Johnson & Johnson (JNJ) traded down 0.27% on Friday, hitting $131.39. It has underperformed by 4.16% the S&P500. On Monday, May 1 Bishop Steven D sold $233,011 worth of Procter & Gamble Co (NYSE:PG) or 2,668 shares. The Williams Jones & Associates Llc holds 626,926 shares with $82.94M value, up from 610,223 last quarter. Zillow Group Inc. now has $4.99B valuation. Middleton And Company Inc Ma holds 2,760 shares or 0.08% of its portfolio. About 725,285 shares traded. It has outperformed by 30.83% the S&P500. Finally, Mountain Capital Investment Advisors Inc bought a new stake in Johnson & Johnson during the second quarter valued at approximately $124,000. The company was maintained on Wednesday, August 5 by Morgan Stanley. Bristol (NYSE:BMY) was raised too. Five equities research analysts have rated the stock with a sell rating, eight have given a hold rating and eight have issued a buy rating to the stock. Therefore 38% are positive. Praxair had 34 analyst reports since August 12, 2015 according to SRatingsIntel. The firm earned "Neutral" rating on Friday, December 16 by Chardan Capital Markets. Jefferies maintained the shares of PG in report on Wednesday, April 19 with "Buy" rating. Johnson & Johnson also recently announced a dividend that was paid on Tuesday the 13th of June 2017. The stock has "Hold" rating by Jefferies on Tuesday, August 15.

Rubin increased her price target for the company to $130 from $125, representing 4 percent downside from Tuesday's close. The rating was downgraded by Deutsche Bank to "Sell" on Wednesday, March 23. The company was maintained on Tuesday, September 12 by Noble Financial. Wells Fargo & Company reiterated a "market perform" rating and issued a $135.00 target price (up previously from $132.00) on shares of Johnson & Johnson in a research note on Thursday, July 6th.

Short interest, or the number of a stock's tradable shares now being shorted, is another metric investors use to get a pulse on sentiment. Its up 0.25, from 0.71 in 2017Q1. It is negative, as 50 investors sold JNJ shares while 878 reduced holdings. Confluence Wealth Management Ltd Liability Com reported 4,609 shares. Winch Advisory Serv Limited Com invested in 0.01% or 87 shares. Parkside Bancshares & Trust stated it has 0% in Ruby Tuesday, Inc. Pnc Fincl Gp has 3,619 shares. Moon Limited Co holds 0% or 6,658 shares in its portfolio. The Vermont-based Hanson & Doremus Investment Management has invested 0.5% in the stock. First Quadrant Limited Partnership Ca reported 259,570 shares or 0.69% of all its holdings. Great West Life Assurance Can reported 0% in Coeur Mining Inc (NYSE:CDE). 39,096 are owned by Natixis.

Among 22 analysts covering Johnson & Johnson (NYSE:JNJ), 10 have Buy rating, 5 Sell and 7 Hold. Aviance Mngmt Ltd has invested 0% in Coeur Mining Inc (NYSE:CDE). New Mexico Educational Retirement Board holds 26,586 shares. CTL has lost -2.76% in the 1-month period. Insider ownership decreased by a total of 185283 shares, which suggests that JNJ's key executives are feeling less optimistic about the outlook for the stock. Spurbeck Mark had sold 16,400 shares worth $159,982 on Thursday, June 8. (NASDAQ:AMKR) to report earnings on October, 30. On average, analysts expect that Johnson & Johnson will post $7.18 EPS for the current fiscal year. The expected JNJ's profit could reach $4.80 billion giving the stock 18.54 P/E in the case that $1.79 earnings per share is reported. After $1.83 actual EPS reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts -2.19% negative EPS growth.

Investors sentiment increased to 1.18 in Q2 2017. Its down 0.03, from 0.86 in 2017Q1. 114 funds opened positions while 731 raised stakes. Hartford Inv reported 1.61% stake. Invest Mgmt Of Virginia Ltd Liability Corporation has invested 1.15% of its portfolio in Johnson & Johnson (NYSE:JNJ). Saratoga Research reported 2.8% stake. Bryn Mawr Trust has invested 2.45% in Johnson & Johnson (NYSE:JNJ). Huntington Savings Bank holds 609,371 shares or 1.41% of its portfolio. Barton Invest Mgmt has 0.76% invested in Johnson & Johnson (NYSE:JNJ). Hussman Strategic Advisors Inc. owns 300,000 shares or 0.65% of their USA portfolio. This nets out to an increase of 2.64 million shares and is a bullish sign for JNJ. Wealthtrust has 1,827 shares. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Fool.com and their article: "10 Rock-Solid Reasons Johnson & Johnson's Near-Term Future Looks Bright" published on September 17, 2017 as well as Providencejournal.com's news article titled: "Raimondo: Johnson & Johnson will occupy portion of Wexford innovation center" with publication date: September 22, 2017. The Japan-based Meiji Yasuda Asset Mngmt has invested 0.83% in Procter & Gamble Co (NYSE:PG). Glenmede Na holds 5.4% in Johnson & Johnson (NYSE:JNJ) or 9.07M shares.

Ratings analysis reveals 45% of Johnson & Johnson's analysts are positive. Caterpillar Inc. had 75 analyst reports since July 27, 2015 according to SRatingsIntel. The firm earned "Hold" rating on Thursday, July 14 by Jefferies. The stock has "Strong-Buy" rating by Vetr on Monday, August 31. Barclays Capital downgraded the shares of JNJ in report on Tuesday, November 29 to "Equal-Weight" rating. The stock presently has a consensus rating of Hold and an average price target of $135.29. (NYSE:CAT) has "Buy" rating given on Monday, September 18 by UBS. As per Friday, September 25, the company rating was maintained by Macquarie Research.